Molecule Information
General Information of the Molecule (ID: Mol01277)
Name |
ADAMTS9 antisense RNA 2 (ADAMTS9-AS2)
,Homo sapiens
|
||||
---|---|---|---|---|---|
Synonyms |
ADAMTS9-AS2
Click to Show/Hide
|
||||
Molecule Type |
LncRNA
|
||||
Gene Name |
HOXA-AS5, HOXA11-AS1, HOXA11AS, HOXA11S, NCRNA00076
|
||||
Gene ID | |||||
Location |
chr3:64684909-65053439[+]
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Tamoxifen
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Breast cancer | [1] | |||
Resistant Disease | Breast cancer [ICD-11: 2C60.3] | |||
Resistant Drug | Tamoxifen | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
Cell proliferation | Activation | hsa05200 | ||
In Vitro Model | MCF-7 cells | Breast | Homo sapiens (Human) | CVCL_0031 |
Experiment for Molecule Alteration |
qRT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
Mechanism Description | Downregulated LncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.